Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...

Topline results expected to be released in August 2025Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc.

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.

This study is the first clinical application of the Company’s proprietary CMND-100 platform and marks a significant milestone in the Company ... is a significant step in our journey toward FDA ...

This follows the March 27 announcement of the product launch and represents a key milestone ... (FDA) has designated YUFLYMA® (adalimumab-aaty), as an interchangeable biosimilar to Humira® (adalimumab ...

Evan Vucci/AP According to Rasmussen's daily poll tracker, as of April 4, Trump's approval rating sits at 49 percent, while 50 percent disapprove of his job performance. That is the first time in ...

A Type A meeting with the FDA is anticipated in May or June to determine the path forward. TD expressed concerns over etripamil’s commercial viability, noting Milestone Pharmaceuticals' limited ...

Milestone is expected to receive $75 million in milestone payments upon FDA approval, with a commercial launch anticipated for mid-2025. This article was generated with the support of AI and ...

Challenges include potential delays in site activation and patient enrollment despite FDA-approved protocol changes. Analysts raised concerns about achieving enrollment milestones tied to funding ...

In connection with the acquisition, the combined company adopted the name Opus Genetics, Inc., and began trading on Nasdaq under the ticker symbol ... in part from a milestone payment of $10.0 million ...